Teva in $40bn push for Mylan as
pharma frenzy heats up -------------- Teva, the largest generic
drugmaker in the world, set the stage for the biggest pharma deal of the year by
launching an unsolicited $40bn offer to buy its nearest rival
Mylan. 梯瓦制藥向邁蘭發(fā)起巨額收購要約 -------------- 世界最大的仿制藥制造商梯瓦(Teva)向其最大競爭對(duì)手邁蘭(Mylan)發(fā)出400億美元的主動(dòng)收購要約,,此舉為今年醫(yī)藥行業(yè)最大一筆并購交易的上演搭好了舞臺(tái),。
|